Pharma CEO says U.S. manufacturing capacity is 'limited' in event of coronavirus vaccine, treatment

Jake Tapper and Leonard Schleifer.
(Image credit: Screenshot/CNN)

Dr. Leonard Schleifer, the CEO of pharmaceutical company Regeneron, is optimistic that there will eventually be a breakthrough when it comes to combating the disease, whether that comes in the form of a drug or a vaccine. But there will still be obstacles, he told CNN's Jack Tapper on Sunday's State of the Union.

Regeneron is developing a coronavirus treatment. If and when a vaccine or treatment hits the market, there's still the question of how people will be able to access it, considering demand will be high, but Schleifer isn't too concerned about distribution — he thinks whatever is available will be at pharmacies and doctors' offices. Instead, he's more worried about the United States' manufacturing capacity, which he described as "limited."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us